Logo Lanfrica
  • Accueil
  • Atlas
  • Analyses
  • Documentation
  • Sign in

© 2026 Lanfrica. Tous droits réservés. Tous les droits d'auteur des ressources affichées sur le site Web Lanfrica appartiennent aux détenteurs de droits d'auteur d'origine, sauf indication contraire explicite.

Holuwarkemmy/Spatial-Risk-Analysis-of-cVDPV2-Poliovirus-in-Nigeria

Domaine:

healthcaregeospatial

Type de record:

project
Créateur:
Hol
Hôte:
# Spatial Risk Analysis of Circulating Vaccine-Derived Poliovirus Type 2 (cVDPV2) in Nigeria ## 1. Introduction Nigeria has made significant progress towards polio eradication; however, the continued circulation of circulating vaccine-derived poliovirus type 2 (cVDPV2) remains a major public health concern. Persistent outbreaks are often driven by immunity gaps, high population concentration, and uneven surveillance performance, necessitating targeted and data-driven responses. Traditional tabular surveillance reports offer limited insight into where transmission risk is concentrated and how interventions should be prioritised geographically. Spatial analysis provides a powerful means of transforming surveillance data into actionable intelligence for immunisation planning and outbreak prevention. This project applies GIS-based spatial analysis and interactive data visualisation to assess cVDPV2 risk at Local Government Area (LGA) level in Nigeria, producing a composite risk index and an operational decision-support dashboard. ## 2. Aim and Objectives ### Aim To identify, classify, and visualise LGA level cVDPV2 transmission risk in Nigeria in order to support targeted public health interventions. ### Objectives • Aggregate ward-level cVDPV2 case data to the Local Government Area (LGA) level and integrate population density to assess transmission potential. • Develop a composite spatial risk index to classify LGAs by cVDPV2 transmission risk. • Visualise and communicate high-risk LGAs through an interactive dashboard to support targeted immunisation and surveillance planning. ## 3. Data Sources ### Datasets Used • Ward level cVDPV2 Surveillance Data • GRID3 Nigeria LGA boundary shapefile • Population Density Raster for under 5 years ## 4. Methodology ### 4.1 Spatial Data Processing (QGIS) • Harmonise and clean all spatial datasets, ensuring consistent coordinate reference systems and standardised LGA and ward identifiers. • Perform spatial j …

Visit

github.com

Similaires

Circulating Vaccine‐Derived Poliovirus Type 2 (cVDPV2) Outbreak Response With Novel Oral Poliovirus Vaccine Type 2 (nOPV2), Sierra Leone's ExperienceTunde1141/Molecular-Epidemiology-of-CVDPV2-in-NigeriaSpatial Analysis of Risk Factors for Childhood Morbidity in Nigerialvcooper/nigeria-cvdpv2-case-controlHoluwarkemmy/Nigeria-Road-Traffic-Accident-2021---2024-Achieving High Poliovirus Antibody Seroprevalence in Areas at Risk of Vaccine-Derived Poliovirus Transmission—Niger Experience

Circulating Vaccine‐Derived Poliovirus Type 2 (cVDPV2) Outbreak Response With Novel Oral Poliovirus Vaccine Type 2 (nOPV2), Sierra Leone's Experience

ABSTRACT Background In March 2024, a circulating vaccine‐derived poliovirus type 2 (cVDPV2) was i

Tunde1141/Molecular-Epidemiology-of-CVDPV2-in-Nigeria

This repo host data files, BEAST XML files, and custom R scripts used for analysis of Nigeria CVDPV2

Spatial Analysis of Risk Factors for Childhood Morbidity in Nigeria

Recent Demographic and Health Surveys (DHS) from Sub-Saharan Africa (SSA) indicate a decline in chil

lvcooper/nigeria-cvdpv2-case-control

Matched case-control analysis of Nigeria cVDPV2 poliomyelitis 2016-2023 # nigeria-cvdpv2-case-contr

Holuwarkemmy/Nigeria-Road-Traffic-Accident-2021---2024-

# Nigeria Road Traffic Accident Analysis (2021 - 2024) ## Overview This project presents an intera

Achieving High Poliovirus Antibody Seroprevalence in Areas at Risk of Vaccine-Derived Poliovirus Transmission—Niger Experience

Abstract Background Outbreaks of vaccine-de